Antineoplastic AgentsDrug Screening Assays, AntitumorCell Line, TumorRadiation, IonizingRadiation DosageNeoplasmsDoxorubicinRadiation InjuriesDrug Resistance, NeoplasmApoptosisAntineoplastic Agents, PhytogenicCell SurvivalDose-Response Relationship, RadiationRadiation ToleranceCisplatinAntibiotics, AntineoplasticRadiationTumor Cells, CulturedDrug CarriersDrug Delivery SystemsDose-Response Relationship, DrugRadiation ProtectionRadiation MonitoringXenograft Model Antitumor AssaysEllipticinesEtoposideMice, NudeCell ProliferationPaclitaxelInhibitory Concentration 50P-GlycoproteinDNA DamageCamptothecinDrug Resistance, MultipleDrug SynergismCell CycleMolecular StructureProdrugsDrug DesignDaunorubicinArea Under CurveDrug Evaluation, PreclinicalPlatinumRadiation OncologyEnzyme InhibitorsTime FactorsBreast NeoplasmsDNA Topoisomerases, Type IIGamma RaysDrug ResistanceFluorouracilRadiation-Sensitizing AgentsAntimetabolites, AntineoplasticTopoisomerase I InhibitorsColonic NeoplasmsNanomedicineNanoparticlesOrganoplatinum CompoundsMitomycinCosmic RadiationRadiation Injuries, ExperimentalGene Expression Regulation, NeoplasticPlant ExtractsNeoplasms, ExperimentalDrug DiscoveryNanocapsulesDNACell DivisionModels, BiologicalAntineoplastic Agents, AlkylatingRadiation PneumonitisCaspasesDrug InteractionsTumor Stem Cell AssayAntineoplastic Combined Chemotherapy ProtocolsLeukemia L1210Tumor Suppressor Protein p53MitoxantroneNeoplasms, Radiation-InducedStructure-Activity RelationshipMolecular Targeted TherapyPrenatal Exposure Delayed EffectsUltraviolet RaysCaspase 3RadiotherapyCombined Modality TherapyDrugs, InvestigationalProto-Oncogene Proteins c-bcl-2Neoplasm TransplantationDNA RepairTriazinesMultidrug Resistance-Associated ProteinsLung NeoplasmsIntercalating AgentsBackground RadiationSignal TransductionDNA AdductsCell LineCell DeathMCF-7 Cells